AU2001281943A1 - The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof - Google Patents

The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof

Info

Publication number
AU2001281943A1
AU2001281943A1 AU2001281943A AU8194301A AU2001281943A1 AU 2001281943 A1 AU2001281943 A1 AU 2001281943A1 AU 2001281943 A AU2001281943 A AU 2001281943A AU 8194301 A AU8194301 A AU 8194301A AU 2001281943 A1 AU2001281943 A1 AU 2001281943A1
Authority
AU
Australia
Prior art keywords
tzon7
protein
polynucleotides
peptides
derived therefrom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001281943A
Inventor
Nalan Utku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8169143&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001281943(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of AU2001281943A1 publication Critical patent/AU2001281943A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Described are polynucleotide encoding TZON7 protein or a biologically fragment thereof. Furthermore, vectors are described comprising said polynucleotides and/or host cells transformed therewith. Additionally, antisense constructs to said polynucleotides are described. Furthermore, methods and uses for modulating immune responses through the TZON7 protein as well as pharmaceutical compositions comprising agents which act on the TZON7 protein are described. Also, the use of said polynucleotides, vectors, proteins or antibodies for the preparation of diagnostic and pharmaceutical compositions for use, inter alia, in organ transplantation, for the treatment of autoimmune, allergic or infectious diseases, or for treatment of tumors is provided.
AU2001281943A 2000-07-03 2001-07-03 The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof Abandoned AU2001281943A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00114234 2000-07-03
EP00114234 2000-07-03
PCT/EP2001/007610 WO2002002619A1 (en) 2000-07-03 2001-07-03 The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof

Publications (1)

Publication Number Publication Date
AU2001281943A1 true AU2001281943A1 (en) 2002-01-14

Family

ID=8169143

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001281943A Abandoned AU2001281943A1 (en) 2000-07-03 2001-07-03 The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof

Country Status (6)

Country Link
US (1) US20030219424A1 (en)
EP (1) EP1297011B1 (en)
AT (1) ATE338063T1 (en)
AU (1) AU2001281943A1 (en)
DE (1) DE60122721T2 (en)
WO (1) WO2002002619A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI118061B (en) * 2001-09-24 2007-06-15 Beanor Oy Procedure and bio donor for analysis
FI115166B (en) * 2001-12-31 2005-03-15 Biofons Oy Diagnostic procedures

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4081000A (en) * 1999-04-09 2000-11-14 Human Genome Sciences, Inc. Uncoupling proteins
EP1190051A2 (en) * 1999-06-17 2002-03-27 Incyte Genomics, Inc. Human transport proteins

Also Published As

Publication number Publication date
DE60122721T2 (en) 2007-10-11
EP1297011B1 (en) 2006-08-30
ATE338063T1 (en) 2006-09-15
EP1297011A1 (en) 2003-04-02
DE60122721D1 (en) 2006-10-12
WO2002002619A1 (en) 2002-01-10
US20030219424A1 (en) 2003-11-27

Similar Documents

Publication Publication Date Title
HK1022918A1 (en) Modified tnfalpha molecules, dna encoding such modified tnfalpha molecules and vaccines comprising such modified tnfalpha molecules and dna
HUP0500345A2 (en) Compositions and methods for the therapy and diagnosis of lung cancer
EP2275553A3 (en) Neisserial antigenic peptides
PL378333A1 (en) Methods for preventing and treating alzheimer's disease (ad)
IL141021A (en) Use of a polypeptide related to copolymer 1 for preparing a medicament for treating autoimmune diseases
AU3126097A (en) Collagen binding protein compositions and methods of use
HUP0202882A2 (en) Novel b7-4 molecules and uses therefor
WO2000034317A3 (en) Method for reducing immunogenicity of proteins
EP1319023B8 (en) An hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof
DK1278534T3 (en) Methods and compositions for attenuating the multiplication of HIV-1
WO2001068708A3 (en) Human and humanized fap-alpha-specific antibodies
DE69032598T2 (en) COMPOSITIONS AND METHODS FOR THE SYNTHESIS OF THE B RECEPTOR FOR THE NATURAL PROTEIN AND METHODS OF USE
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
EP1350848A3 (en) T-cell membrane protein (TIRC7), gene encoding it and antibodies against it and uses thereof
NZ333203A (en) Tumour antigen proteins, genes thereof, and tumour antigen peptides
EP1304123A3 (en) Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
HUP0100267A2 (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
HUP0302566A2 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO1994026903A3 (en) Human influenza virus peptides binding hla-i molecule
AU2001281943A1 (en) The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof
NZ507983A (en) A polypeptide comprising the amino acid of an n- terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
WO2004011496A3 (en) Novel t-cell proteins, peptides and antibodies derived therefrom and uses thereof
AU2001263888A1 (en) Uses of tgap7 for the modulation of leucocyte activation
CA2006587A1 (en) Membrane proteins and peptides of haemophilus influenzae type b
AU1318797A (en) Peptides and uses thereof for therapy of celiac diseases